z-logo
open-access-imgOpen Access
Immediate and late clinical and angiographic outcomes after GFX coronary stenting: Is high‐pressure balloon dilatation necessary?
Author(s) -
Park SeongWook,
Hong MyeongKi,
Lee Cheol Whan,
Kim JaeJoong,
Park HoonKi,
Cho GooYeong,
Kang DukHyun,
Song JaeKwan,
Park SeungJung
Publication year - 2000
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960230810
Subject(s) - medicine , stent , balloon , restenosis , surgery , coronary artery disease , radiology , angioplasty , cardiology
Background : The GFX stent is a balloon‐expandable stent made of sinusoidal element of stainless steel. The adjunct high‐pressure balloon dilatations were usually recommended in routine stenting procedure. Hypothesis : The aim of this study was to evaluate the immediate and long‐term clinical and angiographic outcomes and to investigate the necessity of high‐pressure balloon dilatation during GFX stenting. Methods : In all, 172 consecutive patients underwent single 12 or 18 mm GFX stent implantation in 188 native coronary lesions. Two types of stenting technique were used: (1) stent size of a final stent‐to‐artery ratio of 1:1 (inflation pressure > 10 atm, high‐pressure group), and (2) stent size of 0.5 mm bigger than reference vessel (inflation pressure ≤ 10 atm, low‐pressure group). The adjunct high‐pressure balloon dilatations were performed only in cases of suboptimal results. Results : The adjunct high‐pressure balloon dilatation was required in 11 of 83 lesions (13%) in the high‐pressure group and in 7 of 105 lesions (7%) in the low‐pressure group (p = 0.203). Procedural success rate was 100%. There were no significant differences of in‐hospital and long‐term clinical events between the two groups. The overall angiographic restenosis rate was 17.7%; 18.4% in the high‐pressure group and 17.1% in the low‐pressure group (p = 0.991). Conclusions : The GFX stent is a safe and effective device with a high procedural success rate and favorable late clinical outcome for treatment of native coronary artery disease. Further randomized trials may be needed to compare stenting techniques in GFX stent implantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here